Literature DB >> 27610819

Circulating MicroRNAs in Graves' Disease in Relation to Clinical Activity.

Izumi Hiratsuka1, Hiroya Yamada2, Eiji Munetsuna3, Shuji Hashimoto2, Mitsuyasu Itoh1.   

Abstract

BACKGROUND: Understanding the roles of circulating microRNAs (miRNAs) can provide important and novel information regarding disease pathogenesis and a patient's clinical condition. Circulating miRNAs, such as exosomal miRNA, may regulate various bioactivities related to intercellular communication. However, the circulation of miRNAs in Graves' disease (GD) in relation to disease activity has never been elucidated. This study aimed to identify circulating miRNAs in GD in relation to disease activity and whether their exosomes play a role in the pathogenesis of GD.
METHODS: Circulating miRNAs were measured in serum obtained from seven intractable GD patients, seven GD patients in remission, and seven healthy controls using the miScript miRNA PCR Array. Altered miRNAs selected from array data were validated in 65 subjects. To investigate exosome biology, peripheral blood mononuclear cells (PBMCs) were incubated with exosomes isolated from the subjects' sera. mRNAs were quantified for cytokines using quantitative real-time polymerase chain reaction.
RESULTS: Circulating miR-23b-5p and miR-92a-39 were increased in GD patients in remission compared with intractable GD patients (p < 0.05). On the other hand, let-7g-3p and miR-339-5p were decreased in GD patients in remission compared with intractable GD patients (p < 0.05). Exosomes from intractable GD patients stimulated mRNA expression for IL-1β and TNF-α compared with GD patients in remission or healthy controls.
CONCLUSIONS: This study demonstrates that different levels of circulating miRNAs are associated with intractable GD. Moreover, serum exosomes of patients with intractable GD may activate immune cells, which may play an important role in GD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27610819     DOI: 10.1089/thy.2016.0062

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  20 in total

1.  Serum miR-146a, miR-155, and miR-210 as potential markers of Graves' disease.

Authors:  Lei Zheng; Chunbo Zhuang; Xiaobei Wang; Liang Ming
Journal:  J Clin Lab Anal       Date:  2017-05-31       Impact factor: 2.352

2.  Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.

Authors:  Qiuming Yao; Xuan Wang; Weiwei He; Zhenyu Song; Bin Wang; Jinan Zhang; Qiu Qin
Journal:  Endocrine       Date:  2019-04-04       Impact factor: 3.633

3.  [microRNA let-7g-3p regulates proliferation, migration, invasion and apoptosis of bladder cancer cells by targeting HMGB2].

Authors:  Z Zou; Q Cheng; Z Li; W Gao; W Sun; B Liu; Y Guo; J Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

4.  Differential effects of excess high-fructose corn syrup on the DNA methylation of hippocampal neurotrophic factor in childhood and adolescence.

Authors:  Itsuki Kageyama; Hiroya Yamada; Eiji Munetsuna; Mirai Yamazaki; Yoshitaka Ando; Genki Mizuno; Ryosuke Fujii; Yuki Nouchi; Takuya Wakasugi; Tomohide Sakakibara; Atsushi Teshigawara; Hiroaki Ishikawa; Yohei Shimono; Koji Suzuki; Shuji Hashimoto; Koji Ohashi
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

5.  MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features.

Authors:  A N Kucher; Iu A Koroleva; A A Zarubin; M S Nazarenko
Journal:  Mol Biol       Date:  2022-02-12       Impact factor: 1.540

Review 6.  Noncoding RNAs Carried by Extracellular Vesicles in Endocrine Diseases.

Authors:  Margherita A C Pomatto; Chiara Gai; Maria Chiara Deregibus; Ciro Tetta; Giovanni Camussi
Journal:  Int J Endocrinol       Date:  2018-04-01       Impact factor: 3.257

7.  Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Liraglutide Alters Bone Marrow Exosome-Mediated miRNA Signal Pathways in Ovariectomized Rats with Type 2 Diabetes.

Authors:  Jin Li; Ling-Zhi Fu; Lu Liu; Fen Xie; Ru-Chun Dai
Journal:  Med Sci Monit       Date:  2017-11-14

Review 8.  miRNA Landscape in Pathogenesis and Treatment of Vogt-Koyanagi-Harada Disease.

Authors:  Fabian Vega-Tapia; Mario Bustamante; Rodrigo A Valenzuela; Cristhian A Urzua; Loreto Cuitino
Journal:  Front Cell Dev Biol       Date:  2021-05-10

Review 9.  The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases.

Authors:  Bin Wang; Xiaoqing Shao; Ronghua Song; Donghua Xu; Jin-An Zhang
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

10.  Serum microRNA profiles in athyroid patients on and off levothyroxine therapy.

Authors:  Elske T Massolt; Layal Chaker; Theo J Visser; Ad J M Gillis; Lambert C J Dorssers; Carolien M Beukhof; Boen L R Kam; Gaston J Franssen; Giulia Brigante; Tessa M van Ginhoven; W Edward Visser; Leendert H J Looijenga; Robin P Peeters
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.